Article Details

Antisense Therapeutics Updates Ubout The Phase II Clinical Trial Of Its Immunomodulatory Therapy

Retrieved on: 2019-04-03 19:15:00

Tags for this article:

Click the tags to see associated articles and topics

Antisense Therapeutics Updates Ubout The Phase II Clinical Trial Of Its Immunomodulatory Therapy. View article details on hiswai:

Excerpt

<div>Out of which, five patients are in the treatment phase of the study. Also ... to $9.5 in 2017, according to <b>Arcview Market Research</b> and BDS Analytics.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up